Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go

Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go

Recently, the fifth edition of the WHO classification recognized the thoracic <i>SMARCA4</i>-deficient undifferentiated tumor (SMARCA4-UT) as a separate entity from conventional non-small cell lung cancer with <i>SMARCA4</i> deficiency because of the different clinicopatholog...

Full description

Bibliographic Details
Main Authors: Vito Longo, Annamaria Catino, Michele Montrone, Elisabetta Sara Montagna, Francesco Pesola, Ilaria Marech, Pamela Pizzutilo, Annalisa Nardone, Antonella Perrone, Monica Gesualdo, Domenico Galetta
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:International Journal of Molecular Sciences
Subjects:
SMARCA4-UT
immunotherapy
clinicopathological features
Online Access:https://www.mdpi.com/1422-0067/25/6/3237

Similar Items

Similar Items